AACR Award for Outstanding Achievement in Chemistry in Cancer Research

Nominations for the 2009 Award will open in September 2008.

Learn more about the 2008 recipient Dr. Steven R. Tannenbaum. View the list of all past recipients.  

The Award

The AACR and its Chemistry in Cancer Research Working Group established this Award in 2007 to recognize the importance of chemistry to advancements in cancer research. The Award will be given for outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer. Such research may include, but is not limited to, drug discovery and design; structural biology; proteomics, metabolomics and biological mass spectrometry; chemical aspects of carcinogenesis; imaging agents and radiotherapeutics; and chemical biology.

The winner of the 3rd Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research will give a 50-minute lecture during the AACR Annual Meeting 2009 in Denver, CO, USA (April 18-22, 2009), and will receive a commemorative plaque and a $10,000 honorarium.

Eligibility Criteria

• Candidacy is open to all researchers who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry, or government.
• The Award will be presented to an individual investigator. Two or more individuals may be selected to share the Award when their investigations are closed related in subject matter and have resulted in work worthy of an award.
• Institutions or organizations are not eligible for the Award.
• Selection of the Award winner will be made on the outstanding quality, novelty, and significance of the candidates' chemistry research and its important contributions to cancer research. No regard will be given to race, gender, nationality, geographic location, or religious or political views.
• Prior recipients of the AACR-Bruce F. Cain Memorial Award are not eligible to be nominated for research previously recognized by the Cain Award.
  
  

Nomination Process

Nominations may be made via letter from any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science. Candidates may not nominate themselves. 

Nomination letters must be sent electronically to the AACR by Wednesday, October 15, 2008 at 4:00 p.m., United States Eastern Time. Preferred file formats are *.doc, *.pdf. Your nomination is not considered fully submitted until you receive a confirmation e-mail from the AACR; confirmations will be sent within 2 business days.

The nomination letter must be addressed to the Selection Committee; be written in English; and not exceed 1,000 words. The content should include the following:

• the name of the AACR Award for which the candidate is being nominated;
  
• a brief statement of no more than 50-words summarizing the candidate's cancer research accomplishment(s) for which he or she is being nominated;
  
• a concise description of the candidate's outstanding, novel, and significant chemistry research, which has led to important contributions to the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or the treatment of patients with cancer, with the publications supporting these accomplishments directly referenced within the letter; and
• a concise description of the impact of these accomplishments on the field.

Nominators are asked to maintain the confidentiality of the nomination process and to refrain from informing the candidate about the nomination.

There is no restriction on the number of candidates that may be nominated by any individual scientist. There is no restriction on the number of nominators that may write nomination letters or that may sign a single nomination letter on behalf of a candidate.

Selection

Candidates will be considered by a Selection Committee of international cancer leaders appointed by the President of the AACR. The Committee will consider all nominations as they have been submitted; the Committee may not combine submitted nominations, add a new candidate to a submitted nomination, or otherwise make alterations to the submitted nominations. After careful deliberations by the Committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the Award winner will be made on the basis of the candidate's outstanding, novel, and significant chemistry research related to cancer.  No regard will be given to age, race, gender, nationality, geographic location, or religious or political views.

The winner of the 3rd Annual AACR-CICR Award will be announced in January 2009.

Supporter

Generously supported by GlaxoSmithKline.

Questions?

Monique P. Eversley, Program Associate
+1 (267) 646-0576; monique.eversley@aacr.org

American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404